Sign in
4

Changes in Ownership

Matinas BioPharma Holdings, Inc. Filed Acc 0001493152-23-045167

Options or other derivatives

  • Chief Development Officer acquired 1,300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Matkovits Theresa Chief Development Officer 2023-12-15 Grant or award · Stock Option (right to Buy) +1,300,000 1,300,000 D
Loading xslF345X05/ownership.xml…